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Abstract
The aim of the study was to determine the comparative usefulness of inflammatory markers, in evaluating disease activity in patients with inflammatory bowel disease. Disease activity was assessed by the Mayo Clinic score for ulcerative colitis, and Harvey-Bradshaw score for Crohn's disease. Five hundred normal blood donors who had no underlying inflammatory condition served as controls. The erythrocyte sedimentation rate, platelet and white blood cell count, C reactive protein, and the leucocyte adhesiveness/ aggregation test (LAAT) were determined in each patient. One hundred and twenty four patients with inflammatory bowel disease were tested while in remission and 128 in relapse. Their mean (SD) per cent of aggregated white blood cells in the peripheral blood was 8 (5) and 17 (10) respectively compared with controls 6 (4) (p<0.0001). Moreover, the LAAT could effectively discriminate between various grades of disease activity, the values in patients with active disease being 13 (6) % in mild, 17 (10) % in moderate, and 26 (10)% in severe disease (p<0*0001). Other acute phase reactants including the erythrocyte sedimentation rate, the white blood cell count, the platelet count, neutrophil count, as well as, the C reactive protein concentration did not differentiate as well between the various groups. Using logistic regression analysis to differentiate between inflammatory bowel disease patients in remission or relapse, the LAAT was the single best indicator. The addition of any other test did not contribute to the discrimination. Among Knowledge of the severity of inflammation in inflammatory bowel disease (IBD) is important for evaluation, treatment, and prediction of prognosis. To quantify disease severity several clinical scores1-8 and biochemical indices9-18 for both Crohn's disease (CD) and ulcerative colitis (UC) have been developed; along with the physician's and patient's assessment. These scores, however, were found to be unsatisfactory; partly because of their complexity and partly because of their heavy dependence on subjective symptoms that may be changed by mechanical factors (for example, strictures, resection, etc) rather than by disease activity. The various laboratory indices were also found to be imperfect.
While the extremes in the clinical condition (that is, remission or severe disease) are easily recognised in both UC and CD, minor changes of disease severity are more difficult to detect or quantify. The large number of proposed scores and indices suggest that none is ideal. In this study we have evaluated prospectively, in a large cohort of IBD patients and controls, the usefulness of several common biochemical markers in estimating disease activity. 41 (28) 1-6 (2-1) 12-2 (80) 68 (10) 304 (116) 16 (10) (Table II) statistically significant differences between each of the three groups (controls, remission, relapse) were found only for LAAT, C reactive protein, and erythrocyte sedimentation rate in that order.
Methods

Patients
In UC patients (Table III) only the LAAT and erythrocyte sedimentation rate were significantly different between the three groups.
Analysis of the three subgroups of patients with IBD in relapse: with mild, moderate or severe disease (Table IV) showed that only the LAAT and the erythrocyte sedimentation rate showed statistically significant differences. The unpaired t test with the Bonferroni correction showed that the LAAT was significantly differ- 
0-0001
Data shown as mean (SD). Abbreviations as in Table I. ent between all the three groups, while the erythrocyte sedimentation rate was significantly different only between patients with mild and severe disease. In patients with active CD (Table V) only the LAAT (p<00001) and the erythrocyte sedimentation rate (p<0001) showed significant differences. In patients with active UC only the LAAT showed significant differences between the groups (Table VI) . Data shown as mean (SD). Abbreviations as in Table I. rate became the best indication (p<0001), however, the addition of the platelet count or the C reactive protein, or both, significantly improved the differentiation. The same findings were noted when UC and CD patients were analysed separately. to assume that a correlation exists between the degree of intestinal inflammation and degree of adhesiveness of the cells. This study, which clearly shows a correlation between disease activity and degree of leucocyte adhesiveness, strongly supports this notion. In fact, we have already shown in the past that the LAAT correlates with inflammatory disease activity and that this adhesiveness is correlated to tissue leucostasis.24-30 A stasis like this could contribute to unfavourable local rheology. The role of this increased LAA could be important in determining the extent of ischaemic heart disease or cerebrovascular event.36 37 Such leucostasis is probably present in the inflamed intestine.
Our findings might be relevant in view of studies38-4l showing that by reducing the adhesiveness of white blood cells it is possible to attenuate the inflammatory response. Steroidal and non-steroidal anti-inflammatory agents can reduce the adhesiveness of the leucocytes, and studies are in progress to use antibodies directed to the adhesive epitopes on the leucocytes. Therefore, we believe that our findings should be considered in a broad biological sense of the disease and not taken solely as another acute phase reactant.
We conclude that the LAAT is superior to other acute phase reactants currently used in daily practice to detect the presence of inflammation as well as for the assessment of its severity. In addition, our findings might have biological relevance to the disease process in patients with IBD and its potential manipulation by anti-adhesive agents. 
